Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
May 9, 2024
Novel Measures of Quality of Life for Patients With Thyroid Eye Disease
Linus Amarikwa, Anupam Kotwal
Biotechnology Journal
|
May 27, 2018
Impact of Dean Vortices on the Integrity Testing of a Continuous Viral Inactivation Reactor
Linus Amarikwa, Raquel Orozco, Matthew Brown, et al.
Current Neurology and Neuroscience Reports
|
May 25, 2022
Advances in the Treatment of Thyroid Eye Disease Associated Extraocular Muscle Myopathy and Optic Neuropathy
Tracy J Lu, Linus Amarikwa, Connie M Sears, et al.
Ophthalmic Surgery, Lasers & Imaging Retina
|
July 20, 2022
Vitreofoveal Traction Associated With Pilocarpine for Presbyopia
Linus Amarikwa, Suzanne M Michalak, Susan Caul, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 27, 2022
Teprotumumab-Related Hyperglycemia
Linus Amarikwa, Abubakr Mohamed, Sun H Kim, et al.
Aesthetic Surgery Journal
|
December 28, 2021
#PlasticsTwitter: The Use of Twitter Data as a Tool for Evaluating Public Interest in Cosmetic Surgery Procedures
Samuel A Cohen, Jonathan D Tijerina, Linus Amarikwa, et al.
Aesthetic Surgery Journal
|
June 8, 2022
#CosmeticsTwitter: Predicting Public Interest in Nonsurgical Cosmetic Procedures Using Twitter Data
Samuel A Cohen, Jonathan D Tijerina, Shreya A Shah, et al.
Case Reports in Ophthalmology
|
April 10, 2023
Oral Corticosteroids for Teprotumumab-Related Hearing Loss: A Case Report
Tracy J Lu, Linus Amarikwa, Bryan J Winn, et al.
Communications Medicine
|
July 1, 2026
Paired longitudinal tear proteomics reveals persistent ocular surface dysregulation after teprotumumab therapy in thyroid eye disease
Gabriel Velez, Gia-Han Ngo, Daniel Young, et al.
Biotechnology and Bioengineering
|
November 19, 2017
Design of a novel continuous flow reactor for low pH viral inactivation
Stephanie A Parker, Linus Amarikwa, Kevin Vehar, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
May 9, 2024
Novel Measures of Quality of Life for Patients With Thyroid Eye Disease
Linus Amarikwa, Anupam Kotwal
Biotechnology Journal
|
May 27, 2018
Impact of Dean Vortices on the Integrity Testing of a Continuous Viral Inactivation Reactor
Linus Amarikwa, Raquel Orozco, Matthew Brown, et al.
Current Neurology and Neuroscience Reports
|
May 25, 2022
Advances in the Treatment of Thyroid Eye Disease Associated Extraocular Muscle Myopathy and Optic Neuropathy
Tracy J Lu, Linus Amarikwa, Connie M Sears, et al.
Ophthalmic Surgery, Lasers & Imaging Retina
|
July 20, 2022
Vitreofoveal Traction Associated With Pilocarpine for Presbyopia
Linus Amarikwa, Suzanne M Michalak, Susan Caul, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 27, 2022
Teprotumumab-Related Hyperglycemia
Linus Amarikwa, Abubakr Mohamed, Sun H Kim, et al.
Aesthetic Surgery Journal
|
December 28, 2021
#PlasticsTwitter: The Use of Twitter Data as a Tool for Evaluating Public Interest in Cosmetic Surgery Procedures
Samuel A Cohen, Jonathan D Tijerina, Linus Amarikwa, et al.
Aesthetic Surgery Journal
|
June 8, 2022
#CosmeticsTwitter: Predicting Public Interest in Nonsurgical Cosmetic Procedures Using Twitter Data
Samuel A Cohen, Jonathan D Tijerina, Shreya A Shah, et al.
Case Reports in Ophthalmology
|
April 10, 2023
Oral Corticosteroids for Teprotumumab-Related Hearing Loss: A Case Report
Tracy J Lu, Linus Amarikwa, Bryan J Winn, et al.
Communications Medicine
|
July 1, 2026
Paired longitudinal tear proteomics reveals persistent ocular surface dysregulation after teprotumumab therapy in thyroid eye disease
Gabriel Velez, Gia-Han Ngo, Daniel Young, et al.
Biotechnology and Bioengineering
|
November 19, 2017
Design of a novel continuous flow reactor for low pH viral inactivation
Stephanie A Parker, Linus Amarikwa, Kevin Vehar, et al.
Page
of 3